Procedure
FDG PET CT
FDG PET CT is a medical procedure with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia
NCT02476487
completednot_applicable
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
NCT00537056
unknownphase_4
Evaluation of PET CT in the Management of Patients With Crohn's Disease.
NCT00731809
Clinical Trials (3)
Showing 3 of 3 trials
NCT02476487Not Applicable
The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia
NCT00537056Not Applicable
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
NCT00731809Phase 4
Evaluation of PET CT in the Management of Patients With Crohn's Disease.
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3